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Summary
Two of the three class I alcohol dehydrogenase (ADH)
genes (ADH2 and ADH3) encode known functional var-
iants that act on alcohol with different efficiencies. Var-
iants at both these genes have been implicated in alco-
holism in some populations because allele frequencies
differ between alcoholics and controls. Specifically, con-
trols have higher frequencies of the variants with higher
Vmax (ADH2*2 and ADH3*1). In samples both of al-
coholics and of controls from three Taiwanese popula-
tions (Chinese, Ami, and Atayal) we found significant
pairwise disequilibrium for all comparisons of the two
functional polymorphisms and a third, presumably neu-
tral, intronic polymorphism in ADH2. The class I ADH
genes all lie within 80 kb on chromosome 4; thus, var-
iants are not inherited independently, and haplotypes
must be analyzed when evaluating the risk of alcoholism.
In the Taiwanese Chinese we found that, only among
those chromosomes containing the ADH3*1 variant
(high Vmax), the proportions of chromosomes with
ADH2*1 (low Vmax) and those with ADH2*2 (high Vmax)
are significantly different between alcoholics and con-
trols ( ). The proportions of chromosomes with5P ! 10
ADH3*1 and those with ADH3*2 are not significantly
different between alcoholics and controls, on a constant
ADH2 background (with ADH2*1, ; withP  .83
ADH2*2, ). Thus, the observed differences in theP  .53
frequency of the functional polymorphism at ADH3, be-
tween alcoholics and controls, can be accounted for by
the disequilibrium with ADH2 in this population.
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Introduction
Of the seven known human genes coding for the alcohol
dehydrogenases (ADHs), four code for enzymes cata-
lyzing the initial step in the pathway for the metabolism
of ethanol: ADH1, ADH2, ADH3, and ADH4 (Eden-
berg and Bosron 1997). The class I ADHs (ADH1,
ADH2, and ADH3) exist in a cluster on the long arm
of chromosome 4. ADH4 is in the same region but is
at an unknown distance (Riess et al. 1994). The enzymes
are very similar in sequence and structure but differ in
preferred substrates (Edenberg and Bosron 1997). Two
of the three class I genes are known to have alleles pro-
ducing enzymes that catalyze the oxidation of ethanol
at different rates. The two most common variants of
ADH2 are ADH2*2, which produces an enzyme with
a high Vmax (340 mM/min), and ADH2*1, which pro-
duces an enzyme with a lower Vmax (9 mM/min) (Ed-
enberg and Bosron 1997). In Asian populations, the
ADH2*2 allele is found at higher frequencies in controls
than in alcoholics (Thomasson et al. 1991; Chen et al.
1996; Shen et al. 1997; Tanaka et al. 1997). These func-
tionally different alleles are the result of a single amino
acid substitution at residue 47 in exon 3 (arginine in
ADH2*1 and histidine in ADH2*2), which is the re-
sult of a single-nucleotide difference. A third variant,
ADH2*3, is caused by a single-nucleotide difference in
codon 369 (exon 9), which results in a substitution of
cysteine for arginine (Burnell et al. 1987). ADH2*3 has
a Vmax similar to that of ADH2*2 (320 mM/min) but a
higher Michaelis-Menten constant (Km) for ethanol (36
mM for ADH2*3; 0.94 mM for ADH2*2). Likewise,
the enzyme produced by ADH3*1 has a higher Vmax
(88 mM/min) than that for the enzyme produced by
ADH3*2 (35 mM/min), which also is the result of a
single-nucleotide difference that causes an amino acid
substitution in exon 8 (isoleucine in ADH3*1; valine in
ADH3*2) (Edenberg and Bosron 1997). The ADH3*1
allele is generally found at higher frequencies in controls
than in alcoholics (Chen et al. 1996).
The common ADH variants show distinct population
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distributions. ADH2*2 is present at frequencies 1.59 in
East Asian populations, with the exception of a fre-
quency of .33 among Thais. It is found at frequencies
!.25 in populations from other regions (Goedde et al.
1992; Neumark et al. 1998). The very high frequency
of the ADH2*2 allele in East Asian populations, relative
to frequencies in other regions of the world, has long
been a puzzle. Did it reach such high frequencies because
of some past or present selection, or did it just drift to
high frequency in an ancestral population? The question
has potential health implications if there is some selective
agent that has not been identified. ADH2*3 is present
primarily in African populations and has not been ob-
served in Asian populations (Edenberg and Bosron
1997). ADH3*2 is present in East Asia at frequencies
of .12–.24 (Thomasson et al. 1991; Chen et al. 1996;
Shen et al. 1997), whereas in a sample of mixed Euro-
peans it was reported at a frequency of .39 (Whitfield
et al., in press). The hypothesized medical implication
of these functional variants is that individuals with the
ADH2*2 and/or ADH3*1 allele(s) (the isozymes with
a higher Vmax) are more prone to adverse reactions from
the consumption of ethanol, which reduces the chance
of such individuals becoming alcoholic (Thomasson et
al. 1994; Chen et al. 1996; Tanaka et al. 1997). An ADH
with a higher Vmax should increase the rate at which
ethanol is converted into acetaldehyde, a toxin.
Because the ADH2 and ADH3 loci are only ∼15 kb
apart (Yasunami et al. 1990) and because our previous
studies of Asian populations had shown that linkage
disequilibrium often extends over such a physical dis-
tance in these populations (Lu et al. 1996; Tishkoff et
al. 1996, 1998; Kidd et al. 1998), we examined linkage
disequilibrium at these loci in these populations. If
strong linkage disequilibrium exists, additional factors
could be involved in the phenotypic consequences be-
yond the differences in enzyme activity resulting from
the individual amino acid substitutions. For example, a
regulatory difference in strong disequilibrium with an
amino acid difference could have an important role but
may not have been identifiable in the studies performed
to date. Alzheimer disease recently has provided an ex-
ample of this phenomenon at the apolipoprotein E locus,
where combinations of alleles in the regulatory region
and in the coding region appear to increase disease risk
(Bullido et al. 1998). Nickerson et al. (1998) discuss the
difficulties of assigning causation to a single nucleotide
when many nucleotide differences exist between alleles,
as appears to be common over short molecular distances.
Linkage disequilibrium has been reported between the
two ADH functional variants in a sample of normal
Chinese individuals (Chen et al. 1997), but haplotype
frequencies have not been published. Moreover, func-
tionally neutral polymorphisms, such as previously de-
fined RFLPs (Smith 1986), could provide additional
information; neutral polymorphisms in the ADH genes
have not been previously studied as haplotypes in Asian
populations, but some show disequilibrium in European
populations (Edman and Maret 1992). Valdes and
Thomson (1997) recently proposed a method for the
analysis of different variants in haplotypes to determine
which variants are likely to be causative of a disease and
which are merely associated with a disease because of
linkage disequilibrium.
In an initial attempt to study the population genetics
and evolution of the ADH cluster of genes, we investi-
gated as haplotypes the functional variants at ADH2
and ADH3, as well as an intronic RsaI RFLP (Smith
1986), in four populations: three Taiwanese populations
and one Amerindian population. Samples of alcoholics
and nonalcoholics were studied for the Taiwanese pop-
ulations. The sample of Amerindians was a random sam-
ple of Maya undiagnosed for alcoholism and was used
primarily for the analysis of disequilibrium. As back-
ground, we precisely mapped the RsaI restriction site
polymorphism atADH2, converted it to PCR-based typ-
ing, and collected data for this single-nucleotide poly-
morphism (SNP) in several other populations. Through
analysis of the haplotype data, we find that the observed
differences in frequency of the functional polymorphism
at ADH3 in alcoholics and controls can be accounted
for by the polymorphism’s disequilibrium with ADH2,
in the Taiwanese Chinese population.
Subjects, Material, and Methods
Patients and Controls
All patients were diagnosed, by clinical interview, as
having severe alcohol dependence, according to the
DSM-III-R (Diagnostic and Statistical Manual of Mental
Disorders, 3d ed., revised) criteria (APA 1987). See the
report by Lu et al. (1996) for more details regarding
sample ascertainment, diagnostic procedures, and the
measures of severity used for alcohol dependence. Nor-
mal controls were obtained from the same ethnic groups,
including some medical students among the Taiwanese
Chinese controls, and live in the same geographic areas
as the patients. Men were predominantly included in this
study. All samples were collected with informed consent.
Some of these samples had been studied previously for
DRD2 haplotypes (Lu et al. 1996) and DRD4 poly-
morphisms (Chang et al. 1997), and no associationswith
alcoholism were found.
Population Samples
The two Taiwanese aboriginal populations, the Ami
and Atayal, were studied previously for the DRD2 (Lu
et al. 1996) and DRD4 (Chang et al. 1997) loci and for
a possible joint effect of ADH2, ADH3, andDRD2 (Lee
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et al., in press). The Atayal in this study were sampled
from the eastern region of Taiwan. The samples of Tai-
wanese Chinese included those individuals studied along
with the Ami and Atayal in the three studies mentioned
above and an additional 107 alcoholics and 110 non-
alcoholics included in the study by Lee et al. (in press).
The sample of Taiwanese Chinese controls included
some students. Since alcoholism generally is diagnosed
later in life in Taiwan, some of these controls may be
diagnosed in the future as alcoholics. Therefore, the only
effect of an age-matching discrepancy should be a re-
duction of the statistical power of this study. All the
Chinese are descendants of migrants from the South Fu-
jien province ∼400 years ago, and the typing at multiple
loci of a subset of these individuals demonstrated that
they tend to have a lower average heterozygosity than
do the mainland Chinese, supporting their isolation and
the absence of significant admixture (K. K. Kidd, un-
published data). At loci other than the ADH loci, we
have not detected differences in allele frequencies be-
tween alcoholics and controls (e.g., see Lu et al. 1996;
Chang et al. 1997).
The sample of Maya has been studied for many dif-
ferent genetic markers (see Castiglione et al. 1995;
Chang et al. 1996; Tishkoff et al. 1996, 1998; Calafell
et al. 1998) and is described in detail in the report by
Castiglione et al. (1995). The individuals were normal,
apparently healthy volunteers (76% female) living in the
state of Campeche, Mexico; no diagnoses for alcoholism
or related disorders were performed.
The other populations studied only for the RsaI SNP
are similar to the Maya in that they represent random
population samples and no diagnostic information is
available. The Biaka, Mbuti, Druze, Danish, Finnish,
mixed European, San Francisco (SF) Chinese, Adygei,
Yemenite Jewish, Rondonian Surui, and Karitiana sam-
ples are described in the report by Castiglione et al.
(1995). The Japanese and Cambodian samples are de-
scribed in the report by Mountain and Cavalli-Sforza
(1997). The Nasioi sample is described in the report by
Bowcock et al. (1991). The Cheyenne and Jemez Pueblo
samples are described in the report by Goldman et al.
(1993). The Ticuna sample is described in the report by
Schurr et al. (1990). The Arizona Pima sample is de-
scribed in the report by Price et al. (1992); a subset of
this sample was studied here. The Ethiopian Jewish sam-
ple is described in the report by Zoossmann-Diskin et
al. (1991). The specific samples of Russians, Taiwanese
Hakka, Yakut, and Mexican Pima will be described in
more detail at a later date. Additional information on
all samples studied can be found at the Kidd Lab website
(see Electronic-Database Information).
DNA from the samples of Taiwanese aborigines, the
original Taiwanese Chinese (Lu et al. 1996), the Maya,
and the other samples typed only for the RsaI site poly-
morphism was extracted, by standard phenol/chloro-
form methods, from lymphoblastoid cell lines (Sam-
brook et al. 1986). DNA from the remaining Taiwanese
Chinese was extracted from lymphocytes by use of the
guanidine method (Anderson and Gusella 1984; Sam-
brook et al. 1986; Bowcock et al. 1987).
Mapping and Sequencing
The RsaI site polymorphism originally was identified
as an RFLP by Southern blotting of RsaI-digested ge-
nomic DNA with clone pADH36 (Smith 1986). This
clone was reported to include exon 3 ofADH2 and some
flanking intronic segments, for a total of 1.3 kb of insert
(Smith 1986). The two alleles of the original RFLP are
seen as bands of 1 kb and 500 bp (ADH2*A1 and
ADH2*A2, respectively; Willard et al. 1985), with con-
stant bands of 1.2 kb, 0.62 kb, and 0.46 kb. Since the
smaller allelic band, seen for the ADH2*A2 allele, is
only 500 bp, the polymorphic site must be either within
the segment of DNA corresponding to the clone or
500 bp from this segment. Therefore, we sequenced
the clone, designed PCR primers for different sections
of the region, and amplified the segments from individ-
uals of known genotype for the RsaI RFLP. Once the
segment containing the site was identified by digestion
of the PCR products and then by running them on an
agarose gel, the PCR products from the two alternate
homozygotes (identified in earlier RFLP studies) were
sequenced to identify the nucleotide that differed. The
polymorphic site was within the intron 3 portion of the
cloned sequence. Note that ADH2 is very similar in se-
quence to ADH1 and to ADH3, with considerable sim-
ilarity in the introns as well as near identity of the exons
(Ikuta et al. 1986; Edenberg and Bosron 1997; M. Osier
and K. K. Kidd, unpublished data). As such, care must
be taken to ensure the specificity of the PCR reac-
tion. The initial sequence from a gene-specific clone
(pADH36) was confirmed by the sequencing of PCR
products generated from genomic DNA by use of gene-
specific primers.
Sequencing of the clone and the PCR product of ge-
nomic DNA was performed by cycle sequencing with an
ABI PRISM Dye Terminator Cycle Sequencing Core Kit
on an ABI 373S automatic DNA sequencer. For sequenc-
ing of the clone, vector primers were used to obtain
initial sequences at each end of the insert. Primers then
were designed to sequence further in each direction.
After overlapping sequences were obtained, additional
primers were designed to sequence the strand comple-
mentary to each end of the insert.
Marker Typing
Typing of the RsaI SNP was performed with primers
A2IN3DW1 (5′-TAA CTA GGA CAT TGC CAT ACC-
1150 Am. J. Hum. Genet. 64:1147–1157, 1999
Figure 1 Sequence of pADH36. The location of exon 3 is un-
derlined, and the polymorphic nucleotide for the RsaI SNP is capi-
talized and double underlined (nucleotide 956; C is site absent, and T
is site present). The position of the functional exon 3 SNP is nucleotide
50.
3′) and A2IN3UP2 (5′-GAG CTA AAA CAT ACT TTG
GAT AG-3′). The PCR consisted of 4–8 ng genomic
DNA template/ml, 100 ng each primer/ml, 200 mMdNTP,
1.5 mMMgCl2, 50 mM KCl, 10 mM Tris HCl (pH 8.4),
and 0.5 U AmpliTaq DNA polymerase (Perkin Elmer),
in a total volume of 25 ml. The PCR was performed on
a Perkin Elmer 9600 at 95C for 5 min, followed by 30
cycles of 95C for 40 s, 60C for 30 s, and 72C for 45
s and then by a single incubation at 72C for 10 min.
Primers used for the typing of the RsaI site were suffi-
ciently gene specific to result in a robust test under the
given PCR conditions. Following PCR amplification, the
unpurified product was digested with 5 U RsaI restric-
tion enzyme (Boehringer) at 37C for 3 h. Digested prod-
uct was electrophoresed on a 1.5% agarose gel and was
stained with ethidium bromide, for visualization. The
uncut fragment was 236 bp in length, and the cut frag-
ments were 176 bp and 60 bp in length.
For the Maya, typing of the ADH2 functional poly-
morphism in exon 3 and the ADH3 functional poly-
morphism in exon 8 was performed as described in the
report by Thomasson et al. (1994). For the samples of
Taiwanese, the PCR methods of typing the ADH2 func-
tional polymorphism in exon 3 and the ADH3 func-
tional polymorphism in exon 8 were performed as de-
scribed in the reports by Couzigou et al. (1990) and
Walzer et al. (1993).
Statistical Analyses
Genotype and allele frequencies for each polymor-
phism were calculated by direct counting. The HAPLO
computer program (Hawley and Kidd 1995) was used
to estimate haplotype frequencies from the typing data
for the three polymorphic sites. The program also used
the jackknife procedure to estimate standard errors for
the frequency estimates. Disequilibrium was calculated
by use of the LINKD program (A. J. Pakstis, unpublished
data), which calculates the standard disequilibrium co-
efficientD′, as described elsewhere (Lewontin 1964). The
haplotype method developed by Valdes and Thomson
(1997) was used to evaluate the relative importance of
the polymorphic sites in the determination of suscepti-
bility to alcoholism.
Results
Mapping and Sequencing
The sequence for clone pADH36 is given in figure 1
(GenBank accession number AF040967). The insert is
1,318 bp in length, excluding the base pairs composing
the EcoRI cloning sites. Interestingly, the EcoRI cloning
site at the upstream end of this insert, although clearly
present in the clone, was not seen in the sequence of
genomic PCR product spanning the cloning site, whereas
the downstream EcoRI cloning site was present in the
sequence of genomic PCR product spanning the cloning
site (data not shown). The insert starts 21 bp upstream
of exon 3 and continues 1,157 bp from the downstream
end of exon 3, again excluding the cloning site. The
sequence of exon 3 does not show any deviation from
published sequences (Ikuta et al. 1986; multiple other
references are summarized in Edenberg 1991). The nu-
cleotide responsible for the RsaI SNP is 906 bp down-
stream from the varying nucleotide in the functional
exon 3 SNP.
Global RsaI Frequencies
Frequencies of the RsaI SNP for various populations
are given in table 1. In general, global frequencies of the
ADH2*A1 allele are 1.70, except in Southeast Asian
populations. In most Southeast Asian populations (Tai-
wanese Chinese, SF Chinese, Hakka, Japanese, Ami, and
Atayal) the nearly opposite appears to be true, with
ADH2*A1 frequencies within the range .16–.35 (table
1), which is roughly the same as the frequencies of the
ADH2*A2 allele in African, European, Siberian (Yakut),
and Melanesian (Nasioi) populations. The Cambodians
were the only population in our study with an “inter-
mediate” allele frequency for the ADH2*A1 allele (.40;
table 1). In all three samples of South American Am-
erindian populations, ADH2*A2 alleles were not ob-
served. Although the sample sizes were too small to de-
termine whether ADH2*A2 alleles were not present, the
true frequency is certainly quite low (upper 95% con-
fidence limit: Surui, .049; Karitiana, .029; and Ticuna,
.022).
Haplotype Frequencies and Disequilibrium
The observed numbers of individuals with different
three-site phenotypes are given in table 2. The data on
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Table 1
Allele Frequencies for the ADH2 RsaI SNP Polymorphism
Population
Frequency of
ADH2*A1 Allele Standard Error
No. of
ADH2*A1 Alleles
Total No. of
Chromosomes
Biaka .93 .02 129 138
Mbuti .97 .02 76 78
Ethiopians .93 .05 28 30
Yemenite Jews .91 .03 71 78
Adygei .72 .04 75 104
Druze .74 .04 118 160
Danes .71 .05 61 86
Finns .81 .05 52 64
Russians .74 .05 70 94
Mixed Europeans .70 .04 105 150
SF Chinese .19 .04 19 102
Taiwanese Chinesea .19 .03 14 270
Hakka .20 .04 16 82
Amia .33 .07 28 40
Atayala .21 .06 15 42
Japanese .16 .04 15 96
Cambodians .40 .07 19 48
Nasioi .70 .07 32 46
Yakut .76 .04 74 98
Cheyenne .98 .01 110 112
Jemez Pueblo .92 .03 83 90
Pima, Arizona 1.00 0 100 100
Pima, Mexico .99 .01 178 180
Maya .99 .01 99 100
Ticuna 1.00 0 132 132
Rondonian Surui 1.00 0 60 60
Karitiana 1.00 0 106 106
a Frequencies in the samples of nonalcoholic controls. See tables 2 and 3.
the two functional polymorphisms are complete. There
are several instances of missing RsaI data, but this site
was typed for 87.5% of the sample of alcoholics and
for 94.1% of the sample of controls. Genotypes were
counted directly (homozygotes and single-site hetero-
zygotes) for 87 (68.0%) of 128 alcoholics and for 84
(62.2%) of 135 controls. Only 6 (5.7%) of the 128
alcoholics were triple heterozygotes or possible triple
heterozygotes because of missing RsaI data; only 11
(8.2%) of the 135 controls had such genotypes. Esti-
mated haplotype frequencies and the nomenclature used
for haplotypes are given in table 3.
Undue consideration should not be given to the large
numbers of haplotypes with a frequency of 0. Owing to
the somewhat small sample sizes of the Ami and Atayal,
haplotypes at low frequencies may not have been readily
detectable. The 1-2-A2 haplotype (ADH3*1-ADH2*2-
ADH2*A2) was the most common in all three Asian
populations. The allele frequencies among the Atayal
controls in this study were significantly different from
those reported by Thomasson et al. (1994) for an in-
dependent sample of Atayal. This may be the result of
sampling from different geographic regions for the
Atayal, since the smaller sample size in this study does
not explain the differences. Our sample was selected
from the Taroko Gorge–Hualien area in the eastern re-
gion of Taiwan, which belongs to one of the subtribes
of the Atayal population. The sample studied by Tho-
masson et al. (1994) was from the Taipei area in the
northern region of Taiwan.
The pairwise disequilibrium values (D′) and signifi-
cance values for all polymorphic sites in this study are
listed in table 4. When calculation was possible, pairwise
disequilibrium was significant ( ) between allP ! .005
pairs of sites for all populations, except the Maya. For
the Maya there may not have been sufficient discrimi-
nating power to observe significant disequilibrium, be-
cause frequencies for two of the loci (ADH3 and the
RsaI site) were nearly fixed. As was expected, disequi-
librium between the functional ADH2 polymorphism
and the RsaI SNP (the two closest loci) was greater than
that for the other two pairwise comparisons. There was
no significant difference in linkage disequilibrium be-
tween alcoholics and controls for any pair of loci in any
of the three populations diagnosed.
Predisposition to and Protection against Alcoholism
The Taiwanese Chinese alcoholics have allele fre-
quencies significantly different from those of the Tai-
wanese Chinese controls, for all three polymorphic sites
(table 5). This finding agrees with those of previous stud-
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Table 2
Joint Distribution at Polymorphic Sites, for ADH2, RsaI, and ADH3
ADH2 RsaI ADH3
NO. OF TAIWANESE
CHINESE NO. OF AMI NO. OF ATAYAL
NO. OF
MAYAAlcoholics Controls Alcoholics Controls Alcoholics Controls
22 A2A2 11 35 62 6 11 14 13 0
22 A2A2 12 2 2 0 0 0 0 0
22 A1A2 11 3 0 4 1 1 0 0
22 A1A1 11 1 0 1 2 0 0 0
22 ? 11 7 8 0 0 0 0 0
22 ? 12 1 1 0 0 0 0 0
12 A2A2 11 13 12 2 0 1 1 0
12 A2A2 12 2 3 0 0 0 0 0
12 A1A2 11 9 20 4 4 5 5 0
12 A1A2 12 5 9 0 0 0 0 0
12 A1A2 22 0 1 0 0 0 0 0
12 A1A1 11 1 3 0 1 0 1 5
12 A1A1 12 0 2 0 0 0 0 1
12 ? 11 7 4 0 0 0 0 0
12 ? 12 1 2 0 0 0 0 0
12 ? 22 1 0 0 0 0 0 0
11 A2A2 11 4 1 0 0 0 0 0
11 A2A2 12 1 0 0 0 0 0 0
11 A1A2 11 8 2 1 0 0 0 1
11 A1A2 12 2 0 0 0 0 0 0
11 A1A2 22 1 0 0 0 0 0 0
11 A1A1 11 5 0 2 1 0 0 28
11 A1A1 12 9 1 0 0 0 0 10
11 A1A1 22 4 1 0 0 0 0 1
11 ? 11 1 1 0 0 0 0 0
11 ? 12 5 0 0 0 0 0 0
13 A1A1 11 0 0 0 0 0 0 1
Total (N) 128 135 20 20 21 20 47
ies of ADH3 and ADH2 alleles that have demonstrated
an association between alcoholism and the functional
polymorphisms and is expected for the RsaI SNP, since
tight disequilibrium exists among all three polymor-
phisms. The existence of disequilibrium means that the
frequency differences of individual sites are not inde-
pendent and that causation cannot be inferred from sta-
tistical significance when the sites are considered singly.
Valdes and Thomson (1997) showed that neutral sites
in disequilibrium with a disease-predisposing site should
have the same relative frequencies in samples of affecteds
and controls when the state of the predisposing site is
held constant. Table 6 gives the haplotype-frequency ra-
tios for the Taiwanese Chinese, for the ADH3 and
ADH2 sites. Statistical significance is difficult to address
directly, since we only have estimates of haplotype
frequencies, obtained by use of the expectation-maxi-
mization (EM) algorithm. Instead, we used the contin-
gency-table approach—described by Valdes and Thom-
son (1997) for the two-site model of one susceptibility
site and one neutral site—as an approximation, under
the assumption that the counts are directly calculable
from the estimates of haplotype frequency.
In our analyses, we considered only the expressed sites
at ADH2 and ADH3. The intronicRsaI site was omitted
as almost certainly neutral on the basis of prior consid-
erations and comparable contingency-table analyses
(data not shown) indicating no effect on alcoholism. Any
error in the allocation of chromosomes by the EM al-
gorithm was minimal and did not affect the contingency
analysis, since 193% of all haplotypes in alcoholics and
188% of all haplotypes in controls were counted directly
(which is discussed below in more detail).
Only one of the four ratios is significant, namely, the
ratio comparing ADH2 alleles on the ADH3*1 back-
ground. Thus, we can reject the hypothesis that the
ADH2 alleles are neutral whenwe consider theADH3*1
background. However, we cannot reject the hypothesis
that ADH2 alleles are neutral when we consider the
ADH3*2 background, because that contingency table
did not yield a significant x2 value. This finding likely
was the result of reduced power, owing to small numbers
(single individuals) in the contingency table, since the
difference between alcoholics and controls was nearly
twofold, which is similar to that seen on the ADH3*1
background. In contrast, both ratios for ADH3 alleles,
when either ADH2 background was considered, are
nonsignificant; thus, there is no evidence that the ADH3
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Table 3
Estimates of Haplotype Frequency
POPULATION
AND GROUP 2N
FREQUENCY (JACKKNIFE STANDARD ERROR) OF HAPLOTYPEa
1-1-A1 2-1-A1 1-1-A2 2-1-A2 1-2-A1 2-2-A1 1-2-A2 2-2-A2
Taiwanese Chinese:
Alcoholics 256 .174 (.026) .119 (.024) .153 (.025) .019 (.010) .031 (.014) .0 (.0) .485 (.037) .019 (.009)
Controls 270 .110 (.019) .060 (.017) .071 (.017) .011 (.007) .023 (.012) .0 (.0) .707 (.030) .018 (.010)
Ami:
Alcoholics 40 .214 (.081) .0 (.0) .086 (.047) .0 (.0) .161 (.069) .0 (.0) .539 (.083) .0 (.0)
Controls 40 .175 (.066) .0 (.0) .0 (.0) .0 (.0) .150 (.073) .0 (.0) .675 (.091) .0 (.0)
Atayal:
Alcoholics 42 .118 (.048) .0 (.0) .025 (.025) .0 (.0) .025 (.025) .0 (.0) .833 (.053) .0 (.0)
Controls 40 .149 (.052) .0 (.0) .026 (.026) .0 (.0) .026 (.026) .0 (.0) .799 (.068) .0 (.0)
Maya:
Random 94 .788 (.045) .063 (.027) .011 (.011) .0 (.0) .138 (.038) .0 (.0) .0 (.0) .0 (.0)
a Eight haplotypes can be produced by combinations of the three biallelic markers; of these, seven are estimated to be present in at least
one population. The haplotypes are labeled as the sites occur, in order from 5′ to 3′, in the ADH cluster: ADH3, functional alleles 1 or 2 in
exon 8; ADH2, functional alleles 1 or 2 in exon 3; and ADH2, alleles A1 (site absent) or A2 (site present) at the RsaI SNP in intron 3. For
ease of reading, the sites are separated by hyphens. Thus, 1-2-A1 indicates allele 1 at ADH3, allele 2 at ADH2, and the site-absent allele
at the RsaI site in ADH2. The jackknife standard errors usually are somewhat larger (i.e., 30% larger) than the binomial standard errors
calculated from the sample size and the haplotype-frequency estimate.
Table 4
Pairwise Disequilibrium for Loci
POPULATION
AND GROUP
D′ FOR PAIRED LOCIa
RsaI, ADH2 ADH3, ADH2 ADH3, RsaI
Taiwanese Chinese:
Alcoholics .821 .774 .642
Controls .841 .730 .596
Ami:
Alcoholics .541 NP NP
Controls 1.000 NP NP
Atayal:
Alcoholics .796 NP NP
Controls .820 NP NP
Maya:
Random 1.000 1.000 1.000
a ADH2 and ADH3 refer to the functional polymorphisms in these
genes, and RsaI refers to the SNP in intron 3 of ADH2. The D′ values
given are for significant pairwise disequilibrium ( , ex-′P[D  0] ! .005
cept for the Maya [see Results]). NP  calculation not possible (be-
cause one locus was fixed).
polymorphism has any effect on susceptibility to al-
coholism. From this analysis we can conclude that
ADH2*1 does confer a different level of susceptibility
than ADH2*2 and that ADH2*1 may be the only sig-
nificant variant.
Discussion
In the unusual condition in which genes coding for
very similar activity are molecularly close to each other,
examination of the consequences of the linkage between
the genes becomes important. One consequence may be
linkage disequilibrium, the nonrandom occurrence of
sets of alleles on the chromosomes in the population.
Linkage disequilibrium of a disease gene with a strong
effect to a disease gene with a slightly weaker effect may
distort statistical calculations of individual gene effects
by violation of the assumption of independence. The
only way to determine the individual effects is by exami-
nation of the context in which each gene appears. In
other words, haplotypes must be analyzed in order to
gain an appropriate understanding of the effect of an
individual gene.
In East Asia, the ADH2*A1 allele at the RsaI site
occurs at frequencies !.40; in the rest of the world, fre-
quencies are 1.70. This highly significant difference is
similar to that seen for the ADH2*1 allele (Goedde et
al. 1992). Instead of merely reflecting the ADH2 geno-
typings, however, the RsaI site provides more informa-
tion by subdividing some of the ADH2-ADH3 haplo-
types. This is most obvious for the frequencies of the
1-1-A1 and 1-1-A2 haplotypes. The RsaI site also pro-
vides a theoretically neutral polymorphism to contrast
with the functional variants in the haplotype analysis.
As demonstrated by the disequilibrium values, vari-
ants at the two ADH loci do not occur independently
in these populations. One particular haplotype (1-2-A2)
of the eight possible (including the presumably neutral
RsaI SNP) showed the greatest difference between al-
coholics and nonalcoholics. This haplotype occurred at
a frequency of nearly 71% in the control sample of Tai-
wanese Chinese but at only ∼49% in the alcoholics, a
highly significant difference ( , two-proportionP ! .0001
z-test). There was no comparable reduction for the 1-2-
A1 haplotype, which occurred at a frequency of 2.3%
in controls and 3.1% in alcoholics, a nonsignificant dif-
ference in the opposite direction. This comparison of the
1-2-A1 haplotype has almost no power to detect a dif-
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Table 5
Ratio of Allele Frequencies among Alcoholics to Frequencies
among Controls
POPULATION
RATIO (P VALUE) OF ALLELE FREQUENCIESa
ADH3*1 ADH2*2 ADH2*A2
Taiwanese Chinese .925 (.0087) .715 (!.0001) .838 (.0003)
Ami 1.000 (NA) .848 (.0951) .926 (.3192)
Atayal 1.000 (NA) 1.040 (.3409) 1.040 (.3409)
a Significance measured by a two-proportion z-test of the null hy-
pothesis that the frequency in both samples is the same. NA  not
applicable.
ference of the magnitude seen for the 1-2-A2 haplotype,
because of the rarity of 1-2-A1. However, three other
haplotypes demonstrated a significant difference be-
tween alcoholics and controls, in the opposite direction
of haplotype 1-2-A2 (1-1-A1, ; 2-1-A1,P  .018 P 
; and 1-1-A2, [all P values determined by.008 P  .001
a two-proportion z-test]). These estimates are likely to
be conservative because students were included among
the controls. Alcoholism usually is diagnosed later in life
in Taiwan; therefore, the power to determine differences
should be somewhat reduced, since some younger con-
trols may reveal a susceptibility later in life. A sample
of controls matched more closely in age to the sample
of alcoholics may show an even greater difference in
haplotype frequencies. Haplotype comparisons between
alcoholics and controls had low power within the Ami
and Atayal populations, owing to the small sample sizes,
and are not considered further in this article.
Although not challenging the clear existence of the
functional variation observed at ADH2 and ADH3
(Thomasson et al. 1991; Chao et al. 1994; Chen et al.
1996), the nonrandom association in the Taiwanese Chi-
nese leaves open the question of exactly what is respon-
sible for the different susceptibilities to alcoholism. One
possibility is that there may be other functionally rele-
vant variables on those chromosomes in linkage disequi-
librium. For example, in addition to the highermetabolic
rate for ethanol for ADH2*2, there may be regulatory
differences for ADH2 as well, and the allele with the
more active transcription may exist only in combination
with one haplotype or group of haplotypes with a non-
random representation of ability to metabolize ethanol.
This possibility cannot now be distinguished from the
effects of the amino acid substitution on the risk of
alcoholism.
The demonstration of strong disequilibrium between
the functional variants in ADH3 and ADH2 raises the
question of whether the twoADH3 variants, which have
a smaller difference in Vmax, have an independent effect
on the risk of alcoholism in the Taiwanese Chinese. The
overall frequency of ADH3*1 was .84 in alcoholics and
.91 in controls, but the reduced frequency in alcoholics
was entirely attributable to the 1-2-A2 haplotype: the
other six observed haplotypes were more common in
alcoholics than in controls. The frequencies of three of
the haplotypes withADH2*1were significantly different
between alcoholics and controls, in the opposite direc-
tion of haplotype 1–2–A2, as indicated in the discussion
above (higher frequency in alcoholics). The other three
observed haplotypes have nonsignificant differences be-
tween alcoholics and controls.
The haplotype analysis of Valdes and Thomson (1997)
does not reject the null hypothesis that ADH3 alleles
are neutral; ADH2 allelic variation is sufficient to ex-
plain the different levels of susceptibility to alcoholism.
Although comparisons of ADH2 frequencies on an
ADH3*2 background and of ADH3 frequencies on an
ADH2*2 background have reduced power due to small
numbers of individuals in some cells, there is no such
problem with the comparison of ADH2 frequencies on
an ADH3*1 background and ADH3 frequencies on an
ADH2*1 background. All comparisons were statisti-
cally consistent with no effect of ADH3 alleles. There
was, however, a hint of a very weak effect of ADH3.
When only those haplotypes with the ADH2*1 allele
were considered, the ADH3*1 allele occurred in alco-
holics 0.979 times as frequently as in controls, and the
ADH3*2 allele occurred in alcoholics 1.05 times as fre-
quently as in controls. Thus, numerically, ADH3*1
showed a small decrease in alcoholics, in accordance
with ADH3*1 having a small protective effect indepen-
dent of ADH2*2, but the effect, if real, is very small
and far from being statistically significant.
The question arises of whether any of these analy-
ses of alcoholics owe their significance to use of the
EM algorithm to estimate haplotype frequencies, since
Hardy-Weinberg (H-W) expectations clearly were vio-
lated in the sample of alcoholics. Although an additional
level of uncertainty is added, it actually is quite small
for the analyses in table 5, as can be seen from the “raw”
data in table 2 and from the following discussion. Using
extreme ranges of the possible numbers does not mark-
edly alter the significance levels and leaves the conclu-
sions unaltered.
Except for the multiple heterozygotes, the EM algo-
rithm uses gene counting, which is not affected by de-
partures from H-W ratios. When only the functional
sites are considered, almost 12% of controls are double
heterozygotes, but there is no deviation from H-W ra-
tios; therefore, the use of the EM algorithm to allocate
these counts is appropriate. Only 6.25% of the alco-
holics are double heterozygotes, and there is a clear de-
parture from H-W ratios. There are two components to
H-W ratios, the relative proportions of homozygotes and
heterozygotes and the relative proportions of individual
genotypes within each category. Use of H-W ratios
within the EM algorithm involves estimation of only the
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Table 6
Relative Haplotype Frequencies among Alcoholics and Controls, for the Taiwanese Chinese
Haplotype Ratio Alcoholics Controls P Valuea
∗ ∗f(ADH3 1,ADH2 1)
∗ ∗f(ADH3 1,ADH2 2)
83.7/256 .327  .64132.1/256 .516
48.9/270 .181  .25197.1/270 .730 7 # 10
6
∗ ∗f(ADH3 2,ADH2 1)
∗ ∗f(ADH3 2,ADH2 2)
35.3/256 .138  7.004.9/256 .019
19.2/270 .071  3.804.9/270 .018 .37
∗ ∗f(ADH3 1,ADH2 1)
∗ ∗f(ADH3 2,ADH2 1)
83.7/256 .327  2.4035.3/256 .138
48.9/270 .181  2.5519.2/270 .071 .83
∗ ∗f(ADH3 1,ADH2 2)
∗ ∗f(ADH3 2,ADH2 2)
132.1/256 .516  27.164.9/256 .019
197.1/270 .730  40.564.9/270 .018 .53
NOTE.—Frequencies listed as estimated number of chromosomes/total number of chromosomes (e.g.,
84 estimated chromosomes with the haplotype from alcoholics/256 total chromosomes from alcoholics).
a Significance measured by use of the contingency table of Valdes and Thomson (1997). The2# 2
method tests the null hypothesis that, in the subsample with a specific allele at one site, the ratio of the
number of chromosomes with the two alleles at the second site is the same for alcoholics and controls.
relative proportions of different heterozygous genotypes,
except when data are missing. When only the two-site
data for the two expressed polymorphisms atADH3 and
ADH2 are considered, the EM allocates counts for the
double heterozygotes in the proportion pipj:pkpl, where
i and j index the two cis haplotypes and k and l index
the two trans haplotypes; the frequencies of these four
haplotypes are largely based on the direct counts from
homozygotes and single-site heterozygotes. Unless there
is a cis-trans effect or a functional variant affecting the
two genotypes differently (such as disequilibrium of one
haplotype with an allele at a third site), this is a simple
sampling model and is not affected by population levels
of inbreeding. This model is affected if one of the ho-
mozygous classes is differentially included in the sample,
and, therefore, the underlying frequency of that haplo-
type in the sample is different from what it was in the
population of zygotes. Certain ADH genotypes clearly
are less likely to be found among alcoholics, as indicated
by the data in table 2. However, an improved estimate
will be possible only if the correct model of disequilib-
rium and/or selection is incorporated into the EM al-
gorithm. Since there is no suitable model to use at this
time, the EM algorithm incorporating H-W ratios pro-
vides a reasonable method for estimation of haplotype
frequencies. For alcoholics, the expected ratio pipj:pkpl
based on all genotypes except those of the double
heterozygotes was 1:10.26 for the cis:trans genotypes
among the double heterozygotes ([ADH3*1, ADH2*1/
ADH3*2, ADH2*2]:[ADH3*1, ADH2*2/ADH3*2,
ADH2*1]). For the controls, the same ratio was 1:3.79.
We considered the numeric extremes for the allocation
of the double heterozygotes: the results for ADH2 on
an ADH3*1 background remained highly significant,
and the conclusions were not altered (analysis not
shown).
On the basis of the contingency-table analyses, the
RsaI SNP appears to be functionally neutral (analyses
not shown). Although the frequencies of the RsaI SNP
on an ADH3*1 background yielded nominally signifi-
cant results ( ), without a Bonferroni correction,P  .016
the analyses of the frequencies at the RsaI SNP on ei-
ther ADH2 background were statistically insignificant.
Therefore, the observed significance of the RsaI SNP on
an ADH3*1 background is likely due to disequilibrium
with the ADH2 exon 3 SNP.
The three Taiwanese populations were not tested for
the ADH2*3 allele, which is determined by a nucleotide
difference in exon 9 that changes an arginine to a cys-
teine in position 369 of the protein (Burnell et al. 1987).
This variant has not been found previously in East Asian
populations. The samples of Mayan DNA were tested
for this variant, and one individual was heterozygous.
In fact, since the ADH2*3 allele is determined by a sep-
arate site, it can be ignored in an analysis of the site
determining the ADH2*2 allele. In this case, the rest of
the haplotype was 1-1-A1, and it was counted as such.
The existence of the ADH2*3 allele in the sample of
Maya possibly reflects a small amount of African ad-
mixture in the post-Colombian period. Such admixture
at !5% in this specific sample of Maya has been sug-
gested by findings at other loci (K. K. Kidd, unpublished
data). However, the existence of the ADH2*3 allele at
a low frequency in a heterogeneous sample of Amerin-
dians has been documented by Wall et al. (1997). Al-
though none of the individuals was of purely Amerin-
dian descent, none was of documented African descent.
Thus, a low frequency of this allele possibly is an in-
herent characteristic of Amerindians and is not the result
of recent African admixture. In either case, the finding
of one occurrence of the ADH2*3 allele in the sample
of Maya is not especially unusual.
When haplotypes rather than expressed variants are
considered, nomenclature for alleles becomes more com-
plex. As noted above, the ADH2*2 and ADH2*3 alleles
are not really variants at the same position. As such, it
is not logical to use the haplotype nomenclature that we
used (table 3) and simply substitute allele 3 for allele 2
at ADH2: the sites are on opposite sides of the RsaI site
in intron 3, and the double-mutant haplotype is possible,
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although it may not actually exist. One logical nomen-
clature would be to use the amino acid differences to
label the functional alleles and to consider what are now
called “ADH2*1,” “ADH2*2,” and “ADH2*3” as the
haplotypes representing three of the four possible com-
binations of the particular amino acids in the protein.
This system would be more consistent with the recom-
mendations of Antonarakis and the Nomenclature
Working Group (1998).
Despite the complications of nomenclature and the
unknown metabolic effects of multiple functional poly-
morphisms in each gene, haplotype analysis is more in-
formative than analysis of the polymorphisms individ-
ually, especially since the three class I ADH genes
(ADH1, ADH2, and ADH3) are within a region span-
ning only 80 kb (Yasunami et al. 1990). Because linkage
disequilibrium can extend over dozens of kilobases, as
shown by our haplotype analyses, differences in allele
frequencies at one site, between alcoholics and controls,
can be explained fully by linkage disequilibrium with
another nearby site. Haplotype information requires
more attention than it has been given previously.
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